Healthcare & Life Sciences

SphingoTec

SphingoTec is a Healthcare & Life Sciences startup based in Germany, most recent round Series C+, 3 tracked investors.

Activeseries-c-plus
series-c-plus
Stage
2007
Founded
3
Investors

About SphingoTec

Based in Germany, SphingoTec is a startup founded in 2007. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.

SphingoTec develops and markets in vitro diagnostic (IVD) tests for acute medical conditions such as sepsis, acute heart failure, and acute kidney injury. Their proprietary biomarkers provide actionable information for critical care settings.

Explore SphingoTec's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Germany